Information For Authors
- Author Benefits Program
- Manuscript Submission Guidelines
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
OMICS: A Journal of Integrative Biology seeks high quality, original-research papers dealing with all aspects of integrative biology, diverse “OMICS-es,” such as genomics, transcriptomics, proteomics, metabolomics, pharmacogenomics, physiomics, etc., and their integration, data analysis, and modeling. OMICS: A Journal of Integrative Biology is an interdisciplinary forum of postgenomic biology and medicine for networking researchers from various fields, focusing on applications to study biological problems and foster new biological knowledge. Manuscripts dealing with the ethical, legal, and social implications of the different scientific and technological aspects of integrative biology are also solicited. The Journal will also publish reviews and minireviews pertinent to integrative biology and OMICS-es, as well as meeting abstracts, summaries, commentaries, and book reviews.
Manuscripts submitted to OMICS must not be under consideration elsewhere or have been previously published.
All new manuscripts must be submitted online at:
Preparation of Manuscript
NOTE: All submitted manuscripts will be processed through plagiarism detection software. Plagiarized manuscripts will be rejected immediately.
Please prepare all text manuscripts in Microsoft Word double-spaced in at least 12 pt type. Leave ample margins on both sides, top and bottom.
The first page should include the article title, all contributing authors, and the full mailing address and contact information (telephone, fax, and e-mail) for EACH author listed on the manuscript. Please also indicate the corresponding author and include key words.
Manuscripts should be organized with: (1) a title page containing the full title of the paper with the names, affiliations, and full contact information of all authors; (2) an Abstract of 200 words with key words underlined (reference citations are not permitted in the Abstract); (3) a concise, clearly worded and constructed Introduction; (4) Materials and Methods containing sufficient detail to allow for reproduction; * (5) a Results section; (6) a Discussion involving interpretation of the results including their relationship to the existing body of knowledge in the field; (7) Conclusions; (8) Acknowledgments; (9) Disclosures and (10) References. ** Standard abbreviations as defined by the Journal of Biological Chemistry are acceptable; other necessary abbreviations should be listed as a footnote to appear on the first page of the published article. Authors should review the style and clarity of their manuscripts with colleagues before submission. Please follow the protocol described herein to avoid delay in publication. Authors should note that manuscripts may be edited if needed to ensure clear grammatical English usage. The Editor welcomes suggestions concerning potential reviewers. Please do not leave space between paragraphs within a section.
Supplementary material is welcomed. There are NO restrictions on file types for supplemental information, however, all supplemental data must be uploaded as a single, continuous file. Multiple supplemental files will be returned and a single file will be requested.
*OMICS supports the use of minimum reporting standards as guidance on the level of detail that should accompany a publication; either in the main text, or as supplementary information. We therefore recommend that allow authors and reviewers refer to the MIBBI Portal http://mibbi.org/index.php/MIBBI_Portal and consult any appropriate guidance to be found there.
**Please be extremely careful with the Reference section and precisely follow our sample References (see below). This is by far a major source of errors in the submitted manuscripts.
Tables and Illustrations
Prepare each table with its title in a separate file. Use Arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences. Tables may be prepared in Microsoft Word but presented in the Microsoft Word text document AFTER the references. Each table must be prepared as a separate page. All illustrations should be numbered.A legend should be supplied for each illustration and all legends numbered consecutively and double-spaced in a separate file. Figures should be numbered in the order cited in the text. Images should not show the name of a manufacturer. Please keep in mind that the figures will be reduced, so please do not submit large figures/graphs that contain small type, as the text within the figure will not be readable after reduction
Please follow these guidelines for submitting figures:
Do NOT embed art files into a Word or PDF document.
Line illustrations should be submitted at 900 dpi.
Halftones and color should be submitted at a minimum of 300 dpi.
Each figure must be saved as a separate file. Do not embed figures in the text manuscript.
Save as either TIFF or EPS files.
Color art must be saved as CYMK - not RGB.
Black and White art must be submitted as grayscale – not RGB.
PowerPoint or Excel files cannot be uploaded.
Please name your artwork files with the submitting authors name i.e. SmithFig1.tif, SmithTable2.tif etc. Authors who do not follow these guidelines may have their submission returned to them without being reviewed.
ADDITIONAL INFORMATION ABOUT ART FILES
Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:
• All files should be scanned at 100% size.
• 300 dpi
• Final color mode: cmyk
• save file as: .tif or .eps
If you need directions on how to convert a Power Point slide to acceptable format go to http://home.liebertpub.com/MEDIA/pdf/ppconvert.pdf
All authors submitting color illustrations, including those who have been invited to contribute, must cover the cost of color reproduction. There are two tiers of color publication: Print and online OR online only. Costs are based on the number of figures and pages in a typeset article. Please contact AuthorBenefitsProgram@liebertpub.com for estimates, and for options on discounted services.
Author Disclosure Statement
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.htlm#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist."
Please upload individual files of all manuscript material — do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.
References should begin on a separate page after the text and before the tables. Cite the references in the text by name and date. In the reference list, list the references alphabetically using these guidelines.
List all author names if you have 6 or fewer authors in a citation. If there are more than 6 authors in a citation, use "et al." after listing the first three author names.
Davidson BL, Allen ED, Kozarsky KF, Wilson JM, and Roessler BJ (1993). A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 3, 219–223.
Sambrook J, Fritsch EF, and Maniatis T (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York).
When dates from an unpublished source are given, supply the researcher’s name. If work is in press, give the journal in which it is to be published or the name of the publisher. Abbreviations of journal names should follow the style of Medline.
The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained from the publisher of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote of a reprinted table, or of the legend of a reprinted figure, should read, “reprinted by permission from Jones et al.” and list the appropriate reference. All permissions listings must be shown in the manuscript; they cannot be entered on proofs.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
OMICS: A Journal of Integrative Biology is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740-2100; Fax: (914) 740-2101 home.liebertpub.com
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email email@example.com.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email firstname.lastname@example.org or visit Liebert Open Access for more information.